DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the managem...
DexCom Earnings: What To Look For From DXCM
D.R. Horton Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains
DexCom Inc. Stock Outperforms Competitors On Strong Trading Day
AFLAC Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains
Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program | DXCM Stock News
DexCom Executive Chair Kevin Sayer disposes of 26,756 shares worth $2.04 million